説明
A randomized controlled trial evaluating fermented dairy containing Bifidobacterium lactis DN-173 010 for childhood constipation assessed stool frequency and consistency outcomes. Study enrollment and participant flow are presented.
Figure 1
FlowchartSource Paper
Effect of the consumption of a fermented dairy product containing Bifidobacterium lactis DN-173 010 on constipation in childhood: a multicentre …Cite This Figure
![Figure 1: A randomized controlled trial evaluating fermented dairy containing Bifidobacterium lactis DN-173 010 for childhood constipation assessed stool frequency and consistency outcomes. Study enrollment and participant flow are presented.]() > Source: Merit M Tabbers et al. "Effect of the consumption of a fermented dairy product containing Bifidobacteriu." *BMC pediatrics*, 2009. PMID: [19296845](https://pubmed.ncbi.nlm.nih.gov/19296845/)
<figure> <img src="" alt="A randomized controlled trial evaluating fermented dairy containing Bifidobacterium lactis DN-173 010 for childhood constipation assessed stool frequency and consistency outcomes. Study enrollment and participant flow are presented." /> <figcaption>Figure 1. A randomized controlled trial evaluating fermented dairy containing Bifidobacterium lactis DN-173 010 for childhood constipation assessed stool frequency and consistency outcomes. Study enrollment and participant flow are presented.<br> Source: Merit M Tabbers et al. "Effect of the consumption of a fermented dairy product containing Bifidobacteriu." <em>BMC pediatrics</em>, 2009. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/19296845/">19296845</a></figcaption> </figure>